160 related articles for article (PubMed ID: 23216617)
1. Polycythemia vera, the hematocrit, and blood-volume physiology.
Spivak JL
N Engl J Med; 2013 Jan; 368(1):76-8. PubMed ID: 23216617
[No Abstract] [Full Text] [Related]
2. Treatment target in polycythemia vera.
Spivak JL
N Engl J Med; 2013 Apr; 368(16):1556-7. PubMed ID: 23599949
[No Abstract] [Full Text] [Related]
3. Treatment target in polycythemia vera.
Prchal JT; Gordeuk VR
N Engl J Med; 2013 Apr; 368(16):1555-6. PubMed ID: 23594015
[No Abstract] [Full Text] [Related]
4. Treatment target in polycythemia vera.
Leone G
N Engl J Med; 2013 Apr; 368(16):1555. PubMed ID: 23594014
[No Abstract] [Full Text] [Related]
5. Treatment target in polycythemia vera.
McMullin MF; Harrison CN; Kiladjian JJ
N Engl J Med; 2013 Apr; 368(16):1554-5. PubMed ID: 23594013
[No Abstract] [Full Text] [Related]
6. Treatment target in polycythemia vera.
Marchioli R; Vannucchi AM; Barbui T
N Engl J Med; 2013 Apr; 368(16):1556. PubMed ID: 23594012
[No Abstract] [Full Text] [Related]
7. Cardiovascular events and intensity of treatment in polycythemia vera.
Marchioli R; Finazzi G; Specchia G; Cacciola R; Cavazzina R; Cilloni D; De Stefano V; Elli E; Iurlo A; Latagliata R; Lunghi F; Lunghi M; Marfisi RM; Musto P; Masciulli A; Musolino C; Cascavilla N; Quarta G; Randi ML; Rapezzi D; Ruggeri M; Rumi E; Scortechini AR; Santini S; Scarano M; Siragusa S; Spadea A; Tieghi A; Angelucci E; Visani G; Vannucchi AM; Barbui T;
N Engl J Med; 2013 Jan; 368(1):22-33. PubMed ID: 23216616
[TBL] [Abstract][Full Text] [Related]
8. Risk of thrombosis according to need of phlebotomies in patients with polycythemia vera treated with hydroxyurea.
Alvarez-Larrán A; Pérez-Encinas M; Ferrer-Marín F; Hernández-Boluda JC; Ramírez MJ; Martínez-López J; Magro E; Cruz Y; Mata MI; Aragües P; Fox ML; Cuevas B; Montesdeoca S; Hernández-Rivas JA; García-Gutiérrez V; Gómez-Casares MT; Steegmann JL; Durán MA; Gómez M; Kerguelen A; Bárez A; García MC; Boqué C; Raya JM; Martínez C; Albors M; García F; Burgaleta C; Besses C;
Haematologica; 2017 Jan; 102(1):103-109. PubMed ID: 27686377
[TBL] [Abstract][Full Text] [Related]
9. Polycythemia vera.
Hematol Oncol Clin North Am; 2003 Oct; 17(5):1191-210. PubMed ID: 14560782
[TBL] [Abstract][Full Text] [Related]
10. Polycythemia vera: a review.
Golden C
Clin J Oncol Nurs; 2003; 7(5):553-6. PubMed ID: 14603552
[TBL] [Abstract][Full Text] [Related]
11. Diagnosis and Treatment of Primary Erythrocytosis in a Dog: A Case Report.
Diogo CC; Fabretti AK; Camassa JA; Bonelli Mde A; Arias MV; Pereira PM
Top Companion Anim Med; 2015 Jun; 30(2):65-7. PubMed ID: 26359727
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic recommendations in polycythemia vera based on Polycythemia Vera Study Group protocols.
Berk PD; Goldberg JD; Donovan PB; Fruchtman SM; Berlin NI; Wasserman LR
Semin Hematol; 1986 Apr; 23(2):132-43. PubMed ID: 3704665
[TBL] [Abstract][Full Text] [Related]
13. Different effect of hydroxyurea and phlebotomy on prevention of arterial and venous thrombosis in Polycythemia Vera.
Barbui T; De Stefano V; Ghirardi A; Masciulli A; Finazzi G; Vannucchi AM
Blood Cancer J; 2018 Nov; 8(12):124. PubMed ID: 30478311
[No Abstract] [Full Text] [Related]
14. Polycythemia vera: a retrospective and reprise.
Berlin NI; Wasserman LR
J Lab Clin Med; 1997 Oct; 130(4):365-73. PubMed ID: 9358074
[TBL] [Abstract][Full Text] [Related]
15. New Therapeutic Approaches in Polycythemia Vera.
Falchi L; Newberry KJ; Verstovsek S
Clin Lymphoma Myeloma Leuk; 2015 Jun; 15 Suppl(0):S27-33. PubMed ID: 26297275
[TBL] [Abstract][Full Text] [Related]
16. [Treatment with hydroxyurea of polycythemia vera in a 11 year-old child].
Vodoff MV; Nelken B; Vic P; Farriaux JP
Arch Pediatr; 1996 Sep; 3(9):870-3. PubMed ID: 8949347
[TBL] [Abstract][Full Text] [Related]
17. A reappraisal of the benefit-risk profile of hydroxyurea in polycythemia vera: A propensity-matched study.
Barbui T; Vannucchi AM; Finazzi G; Finazzi MC; Masciulli A; Carobbio A; Ghirardi A; Tognoni G
Am J Hematol; 2017 Nov; 92(11):1131-1136. PubMed ID: 28699191
[TBL] [Abstract][Full Text] [Related]
18. Management of hydroxyurea resistant or intolerant polycythemia vera.
Raman I; Pasricha SR; Prince HM; Yannakou CK
Leuk Lymphoma; 2021 Oct; 62(10):2310-2319. PubMed ID: 33949918
[TBL] [Abstract][Full Text] [Related]
19. Thromboembolic events in polycythemia vera.
Griesshammer M; Kiladjian JJ; Besses C
Ann Hematol; 2019 May; 98(5):1071-1082. PubMed ID: 30848334
[TBL] [Abstract][Full Text] [Related]
20. [Polycythemia vera: current status of therapy].
Lengfelder E; Hehlmann R
Dtsch Med Wochenschr; 2000 Oct; 125(41):1243-7. PubMed ID: 11076265
[No Abstract] [Full Text] [Related]
[Next] [New Search]
